JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model (Q35849213)
Jump to navigation
Jump to search
scientific article published on 27 June 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model |
scientific article published on 27 June 2006 |
Statements
1 reference
JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model (English)
1 reference
Titus J Boggon
1 reference
Gerlinde Wernig
1 reference
Sandra A Moore
1 reference
Ross L Levine
1 reference
Ting-Lei Gu
1 reference
Stefan Fröhling
1 reference
Dana Cullen
1 reference
Roberto D Polakiewicz
1 reference
Olivier A Bernard
1 reference
Benjamin H Lee
1 reference
D Gary Gilliland
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference